Pancreatic polypeptide family motifs and polypeptides comprising the same
    1.
    发明授权
    Pancreatic polypeptide family motifs and polypeptides comprising the same 失效
    胰多肽家族基序和包含其的多肽

    公开(公告)号:US08603969B2

    公开(公告)日:2013-12-10

    申请号:US11055098

    申请日:2005-02-11

    IPC分类号: A61K38/22

    摘要: The present invention relates to novel Pancreatic Polypeptide Family (“PPF”) polypeptides. The PPF polypeptides of the invention generally include at least two PPF motif, have at least 50% sequence identity to PYY (3-36) over its length and will generally retain, at least in part, a biological activity of a PP, PYY or NPY. Preferred PPF polypeptides of the invention are those having a potency in one of the assays described herein (preferably food intake, gastric emptying, pancreatic secretion, or weight reduction assays) which is greater than the potency of PP, NPY, PYY, or PYY(3-36) in that same assay. In one aspect, the PPF polypeptides of the invention include novel PYY analog polypeptides. In another aspect, the PPF polypeptides of the invention include PPF chimeric polypeptides including a fragment of a PP family polypeptide linked to a second PP family polypeptide, wherein each of the first and second fragments includes a PPF motif. Methods of using the PPF polypeptides of the invention, and pharmaceutical compositions including the PPF polypeptides of the invention are also disclosed.

    摘要翻译: 本发明涉及新型胰腺多肽家族(“PPF”)多肽。 本发明的PPF多肽通常包括至少两个PPF基序,其长度与PYY(3-36)具有至少50%的序列同一性,并且通常至少部分地保留PP,PYY的生物学活性或 NPY。 本发明优选的PPF多肽是在本文所述测定之一(优选食物摄取,胃排空,胰腺分泌或重量减轻试验)中具有效力的那些,其大于PP,NPY,PYY或PYY的效力( 3-36)。 一方面,本发明的PPF多肽包括新的PYY类似物多肽。 在另一方面,本发明的PPF多肽包括PPF嵌合多肽,其包括与第二PP家族多肽连接的PP家族多肽的片段,其中第一和第二片段中的每一个包括PPF基序。 还公开了使用本发明的PPF多肽的方法和包括本发明的PPF多肽的药物组合物。

    Exendins and exendin agonists modified with albumin
    3.
    发明授权
    Exendins and exendin agonists modified with albumin 有权
    用白蛋白修饰的毒蜥外泌肽和毒蜥外泌激素

    公开(公告)号:US07608692B2

    公开(公告)日:2009-10-27

    申请号:US12101689

    申请日:2008-04-11

    IPC分类号: A61K38/38 A61K38/28 A61K38/00

    CPC分类号: C07K14/605 A61K47/60

    摘要: Modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.

    摘要翻译: 提供了具有与一种或多种聚乙二醇聚合物连接的毒蜥外泌肽或毒蜥外泌激素的修饰的毒蜥外泌肽和毒蜥外泌肽激动剂,以及相关的制剂和剂量以及施用方法。 这些修饰的毒蜥外泌肽和毒蜥外泌肽激动剂,组合物和方法可用于治疗通过降低血浆葡萄糖或延迟和/或减缓胃排空或抑制食物摄取而受益的糖尿病和病症。

    Methods of Use for Conjugated Exendin Peptides
    5.
    发明申请
    Methods of Use for Conjugated Exendin Peptides 有权
    缀合毒素肽的使用方法

    公开(公告)号:US20080176802A1

    公开(公告)日:2008-07-24

    申请号:US12046038

    申请日:2008-03-11

    CPC分类号: C07K14/605 A61K47/60

    摘要: Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.

    摘要翻译: 提供了具有与一种或多种聚乙二醇聚合物连接的毒蜥外泌肽或毒蜥外泌激素的新型修饰的毒蜥外泌肽和毒蜥外泌肽激动剂,以及相关的制剂和剂量以及施用方法。 这些修饰的毒蜥外泌肽和毒蜥外泌肽激动剂,组合物和方法可用于治疗通过降低血浆葡萄糖或延迟和/或减缓胃排空或抑制食物摄取而受益的糖尿病和病症。

    Anti-diabetic peptides
    6.
    发明授权
    Anti-diabetic peptides 有权
    抗糖尿病肽

    公开(公告)号:US6087334A

    公开(公告)日:2000-07-11

    申请号:US138056

    申请日:1998-08-21

    CPC分类号: C07K14/575 A61K38/00

    摘要: Compounds of formula I which act as amylin agonists with respect to certain desired amylin activities and as calcitonin agonists with respect to certain desired calcitonin activities are provided. Such compounds are useful in treating disturbances in fuel metabolism in mammals, including, but not limited to diabetes mellitus, including Type I diabetes and Type II diabetes. The present invention also relates to methods of treating Type I diabetes, treating Type II diabetes and to methods of beneficially regulating gastrointestinal motility comprising administration of a therapeutically effective among of one of the compounds. Also provided are pharmaceutical composition comprising a compound of formula I and a pharmaceutically acceptable carrier.

    摘要翻译: 提供了相对于某些所需胰淀素活性作为胰岛淀粉样多肽激动剂的相应于某些所需降钙素活性的作为降钙素激动剂的式I化合物。 这些化合物可用于治疗哺乳动物的燃料代谢紊乱,包括但不限于糖尿病,包括I型糖尿病和II型糖尿病。 本发明还涉及治疗I型糖尿病,治疗II型糖尿病的方法和有益地调节胃肠运动的方法,包括给予一种化合物中治疗有效的方法。 还提供了包含式I化合物和药学上可接受的载体的药物组合物。

    MODIFIED EXENDINS AND EXENDIN AGONISTS
    9.
    发明申请
    MODIFIED EXENDINS AND EXENDIN AGONISTS 有权
    修改后的提示和豁免激励

    公开(公告)号:US20120135922A1

    公开(公告)日:2012-05-31

    申请号:US13296120

    申请日:2011-11-14

    IPC分类号: A61K38/17 A61P3/10 C07K19/00

    CPC分类号: C07K14/605 A61K47/60

    摘要: Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.

    摘要翻译: 提供了具有与一种或多种聚乙二醇聚合物连接的毒蜥外泌肽或毒蜥外泌激素的新型修饰的毒蜥外泌肽和毒蜥外泌肽激动剂,以及相关的制剂和剂量以及施用方法。 这些修饰的毒蜥外泌肽和毒蜥外泌肽激动剂,组合物和方法可用于治疗通过降低血浆葡萄糖或延迟和/或减缓胃排空或抑制食物摄取而受益的糖尿病和病症。